| Prediction of acute myeloid leukaemia risk in healthy individuals S Abelson, G Collord, SWK Ng, O Weissbrod, N Mendelson Cohen, ... Nature 559 (7714), 400-404, 2018 | 991 | 2018 |
| Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution M Chan-Seng-Yue, JC Kim, GW Wilson, K Ng, EF Figueroa, GM O’Kane, ... Nature genetics 52 (2), 231-240, 2020 | 690 | 2020 |
| Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial KL Aung, SE Fischer, RE Denroche, GH Jang, A Dodd, S Creighton, ... Clinical Cancer Research 24 (6), 1344-1354, 2018 | 672 | 2018 |
| Essential gene profiles in breast, pancreatic, and ovarian cancer cells R Marcotte, KR Brown, F Suarez, A Sayad, K Karamboulas, ... Cancer discovery 2 (2), 172-189, 2012 | 401 | 2012 |
| GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer GM O’Kane, BT Grünwald, GH Jang, M Masoomian, S Picardo, RC Grant, ... Clinical Cancer Research 26 (18), 4901-4910, 2020 | 356 | 2020 |
| Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases AA Connor, RE Denroche, GH Jang, M Lemire, A Zhang, ... Cancer cell 35 (2), 267-282. e7, 2019 | 242 | 2019 |
| Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism N Levaot, O Voytyuk, I Dimitriou, F Sircoulomb, A Chandrakumar, ... Cell 147 (6), 1324-1339, 2011 | 223 | 2011 |
| Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing A Ståhlberg, PM Krzyzanowski, JB Jackson, M Egyud, L Stein, TE Godfrey Nucleic acids research 44 (11), e105-e105, 2016 | 171 | 2016 |
| Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing A Ståhlberg, PM Krzyzanowski, M Egyud, S Filges, L Stein, TE Godfrey Nature protocols 12 (4), 664-682, 2017 | 161 | 2017 |
| Study of stem cell function using microarray experiments C Perez-Iratxeta, G Palidwor, CJ Porter, NA Sanche, MR Huska, ... FEBS letters 579 (8), 1795-1801, 2005 | 98 | 2005 |
| Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival SH Zaidi, TA Harrison, AI Phipps, R Steinfelder, QM Trinh, C Qu, ... Nature communications 11 (1), 3644, 2020 | 88 | 2020 |
| Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Cι-mediated attenuation of p38 MAP kinase signaling RM Baldwin, M Garratt-Lalonde, DAE Parolin, PM Krzyzanowski, ... Oncogene 25 (20), 2909-2919, 2006 | 81 | 2006 |
| Detection of circulating tumor DNA in plasma: a potential biomarker for esophageal adenocarcinoma M Egyud, M Tejani, A Pennathur, J Luketich, P Sridhar, E Yamada, ... The Annals of thoracic surgery 108 (2), 343-349, 2019 | 61 | 2019 |
| Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discov. 2012; 2: 172–189. doi: 10.1158/2159-8290 R Marcotte, KR Brown, F Suarez, A Sayad, K Karamboulas, ... CD-11-0224, 2012 | 53 | 2012 |
| Interrogation of functional cell-surface markers identifies CD151 dependency in high-grade serous ovarian cancer M Medrano, L Communal, KR Brown, M Iwanicki, J Normand, J Paterson, ... Cell reports 18 (10), 2343-2358, 2017 | 52 | 2017 |
| Plasma circulating tumor DNA as a potential tool for disease monitoring in head and neck cancer M Egyud, P Sridhar, A Devaiah, E Yamada, S Saunders, A Ståhlberg, ... Head & neck 41 (5), 1351-1358, 2019 | 51 | 2019 |
| Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer M Braunstein, L Liao, N Lyttle, N Lobo, KJ Taylor, PM Krzyzanowski, ... Breast Cancer Research 18 (1), 16, 2016 | 46 | 2016 |
| CaPSID: a bioinformatics platform for computational pathogen sequence identification in human genomes and transcriptomes I Borozan, S Wilson, P Blanchette, P Laflamme, SN Watt, ... BMC bioinformatics 13 (1), 206, 2012 | 44 | 2012 |
| Impact of chemical-induced mutational load increase on immune checkpoint therapy in poorly responsive murine tumors EA Kuczynski, J Krueger, A Chow, P Xu, S Man, Y Sundaravadanam, ... Molecular cancer therapeutics 17 (4), 869-882, 2018 | 36 | 2018 |
| Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing JC Kim, PC Zuzarte, T Murphy, M Chan-Seng-Yue, AMK Brown, ... Leukemia 34 (1), 306-311, 2020 | 27 | 2020 |
